Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study
Open Access
- 15 November 2010
- journal article
- research article
- Published by Springer Nature in Critical Care
- Vol. 14 (6) , R205
- https://doi.org/10.1186/cc9327
Abstract
Introduction: This prospective study investigated the predictive value of procalcitonin (PCT) for survival in 242 adult patients with severe sepsis and septic shock treated in intensive care. Methods: PCT was analyzed from blood samples of all patients at baseline, and 155 patients 72 hours later. Results: The median PCT serum concentration on day 0 was 5.0 ng/ml (interquartile range (IQR) 1.0 and 20.1 ng/ml) and 1.3 ng/ml (IQR 0.5 and 5.8 ng/ml) 72 hours later. Hospital mortality was 25.6% (62/242). Median PCT concentrations in patients with community-acquired infections were higher than with nosocomial infections (P = 0.001). Blood cultures were positive in 28.5% of patients (n = 69), and severe sepsis with positive blood cultures was associated with higher PCT levels than with negative cultures (P = < 0.001). Patients with septic shock had higher PCT concentrations than patients without (P = 0.02). PCT concentrations did not differ between hospital survivors and nonsurvivors (P = 0.64 and P = 0.99, respectively), but mortality was lower in patients whose PCT concentration decreased > 50% (by 72 hours) compared to those with a < 50% decrease (12.2% vs. 29.8%, P = 0.007). Conclusions: PCT concentrations were higher in more severe forms of severe sepsis, but a substantial concentration decrease was more important for survival than absolute values.Keywords
This publication has 51 references indexed in Scilit:
- Serum procalcitonin, C‐reactive protein and white blood cell levels following hypothermia after cardiac arrest: a retrospective cohort studyEuropean Journal of Clinical Investigation, 2010
- Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trialThe Lancet, 2010
- Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trialCritical Care, 2009
- Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcomeCritical Care, 2009
- Impact of previous sepsis on the accuracy of procalcitonin for the early diagnosis of blood stream infection in critically ill patientsBMC Infectious Diseases, 2008
- Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either gram negative or gram positive bacteriaBMC Infectious Diseases, 2008
- Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective studyCritical Care, 2007
- Incidence, treatment, and outcome of severe sepsis in ICU-treated adults in Finland: the Finnsepsis studyIntensive Care Medicine, 2007
- Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*Critical Care Medicine, 2006
- Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shockIntensive Care Medicine, 2000